NCT06377046View on ClinicalTrials.gov

Accelerated Pacing in Patients Undergoing Pace-and-ablate Strategy With LBBAP: a Randomized Controlled Pilot Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

May 31, 2026

Conditions
Atrial FibrillationPermanent Atrial FibrillationPersistent Atrial FibrillationPacemaker DDDParoxysmal Atrial Fibrillation
Interventions
DEVICE

Accelerated pacing

The lower rate of the pacemaker will be programmed to 80 bpm in DDDR mode with mode switch to DDIR mode.

DEVICE

Current standard of care

The lower rate of the pacemaker will be programmed to the current standard of care which is 60 bpm in DDDR mode with mode switch to DDIR mode.

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT06377046 - Accelerated Pacing in Patients Undergoing Pace-and-ablate Strategy With LBBAP: a Randomized Controlled Pilot Trial | Biotech Hunter | Biotech Hunter